342 related articles for article (PubMed ID: 31647157)
1. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
[TBL] [Abstract][Full Text] [Related]
2. Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.
Staff NP; Cavaletti G; Islam B; Lustberg M; Psimaras D; Tamburin S
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2(Suppl 2):S26-S39. PubMed ID: 31647151
[TBL] [Abstract][Full Text] [Related]
3. A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.
Sharma A; Johnson KB; Bie B; Rhoades EE; Sen A; Kida Y; Hockings J; Gatta A; Davenport J; Arcangelini C; Ritzu J; DeVecchio J; Hughen R; Wei M; Thomas Budd G; Lynn Henry N; Eng C; Foss J; Rotroff DM
Technol Cancer Res Treat; 2022; 21():15330338221127169. PubMed ID: 36172750
[No Abstract] [Full Text] [Related]
4. Effect of a Complementary/Integrative Medicine Treatment Program on Taxane-Induced Peripheral Neuropathy: A Brief Report.
Ben-Arye E; River Y; Keshet Y; Lavie O; Israeli P; Samuels N
Int J Gynecol Cancer; 2018 Jun; 28(5):1045-1049. PubMed ID: 29561303
[TBL] [Abstract][Full Text] [Related]
5. Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.
Pabst L; Velten M; Fischbach C; Kalish M; Pflumio C; Pivot X; Petit T
Breast J; 2020 Dec; 26(12):2376-2382. PubMed ID: 33307596
[TBL] [Abstract][Full Text] [Related]
6. Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS).
Williams LA; Garcia-Gonzalez A; Mendoza TR; Haq S; Cleeland CS
Support Care Cancer; 2019 Mar; 27(3):1021-1028. PubMed ID: 30094731
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.
Su Y; Huang J; Wang S; Unger JM; Arias-Fuenzalida J; Shi Y; Li J; Gao Y; Shi W; Wang X; Peng R; Xu F; An X; Xue C; Xia W; Hong R; Zhong Y; Lin Y; Huang H; Zhang A; Zhang L; Cai L; Zhang J; Yuan Z
J Natl Cancer Inst; 2020 Jan; 112(1):55-62. PubMed ID: 31093677
[TBL] [Abstract][Full Text] [Related]
8. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
9. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment.
Andersen Hammond E; Pitz M; Shay B
Neurorehabil Neural Repair; 2019 Oct; 33(10):792-799. PubMed ID: 31342880
[TBL] [Abstract][Full Text] [Related]
10. [Expert consensus on standardized management of taxane-related peripheral neuropathy].
Taxane-related Peripheral Neuropathy Standardized Management Group
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):170-179. PubMed ID: 32252195
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer.
Liang C; Zhang Y; Chen QY; Chen WF; Chen MZ
Asia Pac J Clin Oncol; 2024 Apr; 20(2):220-227. PubMed ID: 36658674
[TBL] [Abstract][Full Text] [Related]
12. Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.
Zhai J; Sun X; Zhao F; Pan B; Li H; Lv Z; Cao M; Zhao J; Mo H; Ma F; Xu B
Breast; 2023 Feb; 67():36-45. PubMed ID: 36586272
[TBL] [Abstract][Full Text] [Related]
13. Incidence, description, predictors, and consequences of persistent taxane-induced peripheral neuropathy.
Hertz DL
Curr Opin Support Palliat Care; 2024 Mar; 18(1):30-38. PubMed ID: 38126251
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case-control study.
Kus T; Aktas G; Alpak G; Kalender ME; Sevinc A; Kul S; Temizer M; Camci C
Support Care Cancer; 2016 May; 24(5):2085-2091. PubMed ID: 26546457
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
[TBL] [Abstract][Full Text] [Related]
16. Epothilone-induced peripheral neuropathy: a review of current knowledge.
Argyriou AA; Marmiroli P; Cavaletti G; Kalofonos HP
J Pain Symptom Manage; 2011 Dec; 42(6):931-40. PubMed ID: 21621965
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
Salehifar E; Janbabaei G; Hendouei N; Alipour A; Tabrizi N; Avan R
Clin Drug Investig; 2020 Mar; 40(3):249-257. PubMed ID: 31925721
[TBL] [Abstract][Full Text] [Related]
18. Peripheral nerve damage associated with administration of taxanes in patients with cancer.
Argyriou AA; Koltzenburg M; Polychronopoulos P; Papapetropoulos S; Kalofonos HP
Crit Rev Oncol Hematol; 2008 Jun; 66(3):218-28. PubMed ID: 18329278
[TBL] [Abstract][Full Text] [Related]
19. Peripheral neuropathy induced by microtubule-stabilizing agents.
Lee JJ; Swain SM
J Clin Oncol; 2006 Apr; 24(10):1633-42. PubMed ID: 16575015
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the traditional Chinese medicine, Buyang Huanwu Decoction, at preventing taxane-induced peripheral neuropathy in breast cancer patients: A prospective, randomized, controlled study.
Luo F; Wan D; Liu J; Chen D; Yuan M; Zhang C; Liu Q
Medicine (Baltimore); 2024 Mar; 103(9):e37338. PubMed ID: 38428887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
